PARIS, France—New dyslipidemia guidelines from the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) advocate a “lower is better” and risk-based approach for LDL ...
Leading medical groups have released new guidelines for managing cholesterol. High cholesterol remains a major risk factor for heart attack and stroke. The updated guidance calls for earlier screening ...
New ACC/AHA cholesterol guidelines promote earlier detection, personalized risk assessment, and more aggressive LDL ...
PHILADELPHIA, PA—Prescribing statins to achieve a more aggressive LDL treatment target in patients who have had a TIA or ischemic stroke of atherosclerotic origins reduces the risk of major ...
More intensive use of lipid-lowering drugs to reach a lower target for low-density lipoprotein cholesterol (LDL-C) reduced the rate of major cardiovascular (CV) events by one third among people with ...
Ez-PAVE delivers the first direct trial evidence that targeting LDL below 55 mg/dL is superior to below 70 mg/dL in ASCVD patients—providing proof of concept for treat-to-target strategies and a ...
How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to ...
The American Heart Association, along with 10 other leading medical groups, recently issued new guidelines for managing cholesterol. The recommendations aim to support the 86 million U.S. adults with ...
Cholesterol testing should begin as early as age 10, new guidelines suggest. The American Heart Association, along with 10 other leading medical groups, recently issued new guidelines for managing ...